The association of body mass index with safety and effectiveness of first-line carboplatin-based chemotherapy in patients with metastatic non-small cell lung cancer

The association of body mass index with safety and effectiveness of first-line carboplatin-based chemotherapy in patients with metastatic non-small cell lung cancer

Introduction: Carboplatin is an anticancer drug used for treatment of various types of cancer including non-small cell lung cancer (NSCLC). Dosing is based on estimated glomerular filtration rate (GFR) using the Cockcroft-Gault formula. In overweight patients, the GFR is more likely overestimated, r...

Full description

Bibliographic Details
Main Authors: M.P. Kicken, H.D. Kilinc, C.M. Cramer-van der Welle, S. Houterman, B.E.E.M. van den Borne, A.A.J. Smit, E.M.W. van de Garde, M.J. Deenen
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Overweight
BMI
NSCLC
Overdosing
Toxicity
Survival
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222001678

Internet

http://www.sciencedirect.com/science/article/pii/S2468294222001678

Similar Items